[27] have noted an increased incidence of pneumonia associated with PD‐1 inhibitors in NSCLC patients as opposed to PD‐L1 inhibitors, such observations were not replicated in our analysis. The gene discussed is CD274; the disease is susceptibility to pneumonia measurement.